Equity Details
Price & Market Data
Price: $67.00
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $3,337,423,872
Daily Volume: 0
Performance Metrics
1 Week: -7.64%
1 Month: %
3 Months: -19.93%
6 Months: -19.11%
1 Year: -38.54%
YTD: -19.93%
About DiaSorin S.p.A. (DSRLF)
Explore the latest financial data for DiaSorin S.p.A. (DSRLF). Price: 67.00, daily change: $0.00 / 0.00%. Market cap: 3,337,423,872. Performance over 1-month, 6-month, and 1-year.
Company Details
Employees: 3272
Sector: Health technology
Industry: Medical specialties
Country: Italy
Details
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.